1 Min Read
July 12 (Reuters) - Cipher Pharmaceuticals Inc
* Cipher Pharmaceuticals announces ozenoxacin accepted for review by Health Canada Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.